Latest News about GPCR
Recent news which mentions GPCR
   Eli Lilly's Rare Weight Loss Data Miss Could Benefit Competitors
   
  
  
  August 07, 2025
  From Benzinga
 From Benzinga
 From Motley Fool
 From Benzinga
 
   The State of Weight Loss Drugs
   
  
  
  March 10, 2025
  From Motley Fool
 
   Why Structure Therapeutics Stock Was Stumbling This Week
   
  February 14, 2025
  Tickers 
   GPCR
  
  
  From Motley Fool
 
   Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst
   
  
  
  January 06, 2025
  From Benzinga
 
   Heico, Corvus Pharmaceuticals, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session
   
  
  
  December 18, 2024
  From Benzinga
 
   Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition
   
  
  
  October 23, 2024
  From Benzinga
 
   10 Health Care Stocks With Whale Alerts In Today's Session
   
  
  
  October 16, 2024
  From Benzinga
 
   Prime Medicine, MINISO Group, Li Auto, Weibo And Other Big Stocks Moving Higher On Monday
   
  
  
  September 30, 2024
  From Benzinga
 
   3 Promising Biotech Stocks for the Long-Term: August 2024
   
  
  
  August 13, 2024
  From InvestorPlace
 Tickers 
   GPCR
  
  
  From InvestorPlace
 From InvestorPlace
 From Motley Fool
 
   Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
   
  
  
  July 17, 2024
  From Benzinga
 From Benzinga
 
   ASML Reports Q2 Results, Joins Spirit Airlines And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
   
  
  
  July 17, 2024
  From Benzinga
 From InvestorPlace
 
   The 3 Smartest Biotech Stocks to Buy With $5K Right Now
   
  
  
  June 28, 2024
  From InvestorPlace
 From Motley Fool
 
   Structure Therapeutics Stock Could Rocket 87% Higher, According to 1 Wall Street Analyst. Is It Time to Buy?
   
  
  
  June 11, 2024
  From Motley Fool
 
   Structure Therapeutics' Stock Is Soaring on the Promise of Its Wegovy Competitor, but Is It a Buy?
   
  
  
  June 09, 2024
  From Motley Fool
 From InvestorPlace
 Tickers 
   GPCR
  
  
  From InvestorPlace
 
   Structure Therapeutics' Obesity Candidate Is ' Very Competitive' To Eli Lilly's Orforglipron, Analyst Says
   
  
  
  June 03, 2024
  From Benzinga
 From Benzinga
 From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.